Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies
Saskia Räuber(Düsseldorf University Hospital), Nico Melzer(Düsseldorf University Hospital), Melanie Korsen(Heinrich Heine University Düsseldorf), Marion Rapp(Düsseldorf University Hospital), Norbert Goebels(Heinrich Heine University Düsseldorf), Christina B. Schroeter(University of Münster), Sven G. Meuth(University Hospital Münster), Sumanta Barman(Düsseldorf University Hospital), Heinz Wiendl(University Medical Center Freiburg), Lars Masanneck(Heinrich Heine University Düsseldorf), Tobias Ruck(BG University Hospital Bergmannsheil Bochum), Oliver Grauer(University Hospital Münster), Michael Hanke(Forschungszentrum Jülich), Stefanie Lichtenberg(University of Münster), Andreas Schulte‐Mecklenbeck(University Hospital Münster), Werner Paulus(Institute of Neuroimmunology of the Slovak Academy of Sciences), Andre Dik(Augenstern), Catharina C. Groß(University Hospital Münster), Alice Willison(Düsseldorf University Hospital), Christine Strippel(University Hospital Münster), Marc Pawlitzki(Heinrich Heine University Düsseldorf), Michael Sabel(Düsseldorf University Hospital), Katharina J. Weber(Goethe University Frankfurt), Marco Gallus(Heidelberg University), Ruth Kerkhoff(Düsseldorf University Hospital), Duygu Pul(Düsseldorf University Hospital), Stjepana Kovac(University of Münster), M Jonas(Düsseldorf University Hospital), Kristin S. Golombeck(University of Münster), Ramona Hagler(Düsseldorf University Hospital), Guido Reifenberger(Düsseldorf University Hospital)
Cited by 10
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Ofatumumab versus Teriflunomide in Multiple Sclerosis
|New England Journal of Medicine|2020|706
How patients with multiple sclerosis acquire disability
|Brain|2022|532
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293